Germany’s Merck is on the verge of a billion-euro takeover of US biopharmaceutical company Springworks Therapeutics, with the sides now in “advanced talks” about a purchase, Merck said on Friday. The deal would be the largest acquisition in years for the DAX-listed pharmaceutical company based in Darmstadt and strengthen its cancer drugs business. US media […]